Claims for Patent: 3,985,758
✉ Email this page to a colleague
Summary for Patent: 3,985,758
| Title: | 1,4-Dihydropyridine derivatives |
| Abstract: | There are provided novel 1,4-dihydropyridine derivatives, particularly 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3- beta -(N-benzyl-N-methylamino)ethyl ester and 5-methyl ester. The 1,4-dihydropyridine derivatives are characterized by cerebral vascular dilator activity. |
| Inventor(s): | Masuo Murakami, Kozo Takahashi, Masaru Iwanami, Masaharu Fujimoto, Tadao Shibanuma, Ryutaro Kawai, Toichi Takenaka |
| Assignee: | Yamanouchi Pharmaceutical Co Ltd , Bristol Myers Squibb Pharma Co |
| Application Number: | US05/584,268 |
| Patent Claims: |
1. A compound of the formula ##SPC10##wherein R represents hydrogen or lower alkyl; R1 and R2 each represents methyl; R3 represents phenyl, benzyl, halobenzyl, lower alkoxy-benzyl; R4 represents hydrogen, methyl or ethyl; A represents lower alkylene; R5 represents methyl, or lower alkoxy, or lower alkoxy substituted with lower alkoxy, or ##EQU1## in which R3 and R4 have the same meaning as above; and R6 represents nitro or trifluoromethyl. 2. The 1,4-dihydropyridine compound as claimed in claim 1 wherein said R is hydrogen, said R1 and R2 each represents methyl; said R3 represents benzyl; said R4 represents methyl or ethyl; said R5 represents lower alkoxy; and said R6 represents nitro. 3. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-(N-benzyl-N-methylamino ethyl ester 5-methyl ester. 4. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-(N-benzyl-N-methylamino) ethyl ester 5-ethyl ester. 5. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-(N-benzyl-N-methylamino) ethyl ester 5-isopropyl ester. 6. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-(N-benzyl-N-ethylamino) ethyl ester 5-isopropyl ester. 7. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-(N-benzyl-N-methylamino) propyl ester 5-isopropyl ester. 8. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-(N-p-methoxybenzyl-N-methylamino) ethyl ester 5-ethyl ester. 9. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-(N-p-chlorobenzyl-N-methylamino) ethyl ester 5-ethyl ester. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
